UNITED STATES, WASHINGTON (VOP TODAY NEWS) — Pancreatic cancer is one of the most deadly diseases. Due to the fact that the disease is often detected in the later stages, it is rather difficult to treat the disease. Researchers from Columbia University have proposed a new combination of drugs, the use of which will help to more effectively deal with tumors.
The main difficulty, Kenneth Olive explains in the treatment of pancreatic tumors, is that a thick layer of connective tissue is formed around such formations – its presence prevents the drugs from acting on the malignant cells.
The authors proposed a new medicine that they promise will be truly effective. This is a drug based on the compound PTC596, a substance that has already established itself in laboratory experiments in the treatment of this form of cancer.
Scientists tested PTC596 in combination with gemcitabine, which is now used as a first-line drug in the treatment of pancreatic cancer.
A combination of drugs was administered to mice with an aggressive form of cancer that was resistant to chemotherapeutic drugs. Rodents that received 2 drugs instead of one lived three times longer than those treated only with gemcitabine.
The authors do not exclude that such a combination of drugs will be effective for people – while this has yet to be verified. It is important to learn about how safe such treatment will be.
This article is written and prepared by our foreign editors writing for VOP from different countries around the world – edited and published by VOP staff in our newsroom.
Contact us: email@example.com
VOP Today News — Breaking news source, real-time coverage of the world’s events, life, politics, business, finance, economy, markets, war and conflict zones.
We are the Voice of People — the only funding and support we get from people – we are categorically not funded by any political party, any government somewhere or from any grouping that supports certain interests – the only support that makes VOP possible came from you.